Willingness to pay to assess patient preferences for therapy in a Canadian setting

Marra, Carlo A.; Frighetto, Luciana; Goodfellow, Alan F; Wai, Amy O; Chase, Margaret; Nicol, Ruth E; Leong, Carole A; Tomlinson, Sally; Ferreira, Barbara M; Jewesson, Peter J.

doi:10.1186/1472-6963-5-43

Cited by 46 publications

(39 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Administration by self or a care-giver abates the need for transporting the patient to the hospital each day, whilst services featuring hospital nurses who deliver home therapy would cater to patients with decreased mobility due to disease or social factors. It has been reported that the majority of OPAT patients prefer to receive treatment in a home setting rather than a hospital setting [23]. Accordingly, to attract patients to these alternative service delivery models, similar subsidy and government support should also be granted to these patients.…”

Section: Discussionmentioning

confidence: 98%

A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective

Yong

Fisher

Sklar

et al. 2009

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 98%

A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective

Yong

Fisher

Sklar

et al. 2009

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

“…OPAT has been championed as an approach to ED because it may reduce the cost of treatment and is preferred by patients over i.v. administration in a hospital [76]. However, the use of OPAT with many of the current parenteral agents is challenged by the availability of oral formulations of linezolid and tedizolid phosphate and by longer-acting agents such as oritavancin and dalbavancin, which either avoid or minimise the need for additional infusions.…”

Section: Article In Pressmentioning

confidence: 96%

Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe

Nathwani

Dryden

Garau

2016

International Journal of Antimicrobial Agents

View full text Add to dashboard Cite

Skin and soft-tissue infections (SSTIs) are a common indication for antibiotic use in Europe and are associated with considerable morbidity. Treatment of SSTIs, occasionally complicated by infection with meticillin-resistant Staphylococcus aureus, can be resource intensive and lead to high healthcare costs. For patients treated in an inpatient setting, once the acute infection has been controlled, a patient may be discharged on suitable oral antibiotic therapy or outpatient parenteral antibiotic therapy. The recently confirmed efficacy of single-dose (e.g. oritavancin) and two-dose (e.g. dalbavancin) infusion therapies as well as tedizolid phosphate, a short-duration therapy available both for intravenous (i.v.) and oral use, for treating SSTIs has highlighted the need for clinicians to re-evaluate their current treatment paradigms. In addition, recent clinical trial data reporting a novel endpoint of early clinical response, defined as change in lesion size at 48-72 h, may be of value in determining which patients are most suitable for early de-escalation of therapy, including switch from i.v. to oral antibiotics, and subsequent early hospital discharge. The aim of this paper is to review the potential impact of assessing clinical response on clinical decision-making in the management of SSTIs in Europe, with a focus on emerging therapies.

show abstract

“…Aspects of convenience valued can be classified broadly into two categories: Those relating to the administration of an intervention, for example, dosing frequency or mode of administration [13,15,18,19,21,23,24,26,[30][31][32][33][34][36][37][38][39], and those looking at ease of access to an intervention, for example, distance to travel [14,16,17,20,25,28,29,35]. Two studies spanned both categories [22,27].…”

Section: Key Characteristics Of Studiesmentioning

confidence: 99%

“…Studies identified and reviewed were published between 1996 and 2013, and came from Canada (n ¼ 7) [13][14][15][16][17][18][19], the United States (n ¼ 3) [20][21][22], the United Kingdom (n ¼ 3) [23][24][25], Scotland (n ¼ 3) [26][27][28], Australia (n ¼ 3) [29][30][31], Sweden (n ¼ 2) [32,33], Denmark (n ¼ 1) [34], Germany (n ¼ 1) [35], Italy (n ¼ 1) [36], and Spain (n ¼ 1) [37]. Two studies had multinational perspectives [38,39].…”

Section: Key Characteristics Of Studiesmentioning

confidence: 99%

Does Convenience Matter in Health Care Delivery? A Systematic Review of Convenience-Based Aspects of Process Utility

Higgins

Barnett

Meads³

et al. 2014

Value in Health

View full text Add to dashboard Cite

Objectives: To systematically review the existing literature on the value associated with convenience in health care delivery, independent of health outcomes, and to try to estimate the likely magnitude of any value found. Methods: A systematic search was conducted for previously published studies that reported preferences for convenience-related aspects of health care delivery in a manner that was consistent with either cost-utility analysis or cost-benefit analysis. Data were analyzed in terms of the methodologies used, the aspects of convenience considered, and the values reported. Results: Literature searches generated 4715 records. Following a review of abstracts or full-text articles, 27 were selected for inclusion. Twentysix studies reported some evidence of convenience-related process utility, in the form of either a positive utility or a positive willingness to pay. The aspects of convenience valued most often were mode of administration (n ¼ 11) and location of treatment (n ¼ 6). The most common valuation methodology was a discrete-choice experiment containing a cost component (n ¼ 15). Conclusions: A preference for convenience-related process utility exists, independent of health outcomes. Given the diverse methodologies used to calculate it, and the range of aspects being valued, however, it is difficult to assess how large such a preference might be, or how it may be effectively incorporated into an economic evaluation. Increased consistency in reporting these preferences is required to assess these issues more accurately.

show abstract

Willingness to pay to assess patient preferences for therapy in a Canadian setting

Cited by 46 publications

References 21 publications

A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective

A cost analysis of Outpatient Parenteral Antibiotic Therapy (OPAT): an Asian perspective

Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe

Does Convenience Matter in Health Care Delivery? A Systematic Review of Convenience-Based Aspects of Process Utility

Contact Info

Product

Resources

About